Clinical Trial

Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study

Name: Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study — clinical trial record (NCT07257068)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To find out if taking a drug called infliximab (the "study drug") is safe and effective in reversing insulin dependence in CIADM.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-21.

Trial Details

NCT Number	NCT07257068
Lead Sponsor	M.D. Anderson Cancer Center
Conditions	Checkpoint Inhibitor, Pilot Study, Diabetes Melletus
Enrollment	14 participants
Start Date	2026-09-14
Primary Completion	2027-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-23